The many faces of IgG4-related disease: report of a case with inaugural recurrent aortic aneurism ruptures and literature review

Rheumatol Int. 2018 Aug;38(8):1565-1570. doi: 10.1007/s00296-018-4046-9. Epub 2018 May 12.

Abstract

Vascular involvement in IgG4-related disease (IgG4-RD), is a well-recognized feature and large vessel commitment, especially the aorta, can be the only manifestation of the disease. Being a newly recognized disease, its diagnosis and workup still represents a challenge in clinical practice. A 47-year-old-man with two aortic aneurysms ruptures, one at abdominal and the other at thoracic level, was referred to our rheumatology department. The initial analysis of the surgical specimen obtained 3 years earlier revealed a nonspecific aortitis. Re-evaluation of the biopsy with immunohistology now demonstrated the presence of IgG4 deposits. Evidence-based recommendations regarding diagnosis, treatment and follow-up of IgG4-related large-vessel involvement are lacking. In this particular case, histopathology were crucial. The authors review and discuss vascular involvement in IgG4-RD and respective treatment options.

Keywords: Aortitis; IgG4 related-disease; Large-vessel disease; Treatment.

Publication types

  • Case Reports
  • Systematic Review

MeSH terms

  • Aged
  • Aortic Aneurysm, Abdominal / immunology*
  • Aortic Aneurysm, Abdominal / pathology
  • Aortic Aneurysm, Thoracic / immunology*
  • Aortic Aneurysm, Thoracic / pathology
  • Aortic Rupture / etiology*
  • Aortic Rupture / immunology
  • Aortic Rupture / surgery
  • Aortitis / blood
  • Aortitis / complications
  • Aortitis / drug therapy
  • Aortitis / immunology*
  • Biomarkers / blood
  • Female
  • Humans
  • Immunoglobulin G4-Related Disease / blood
  • Immunoglobulin G4-Related Disease / diagnosis
  • Immunoglobulin G4-Related Disease / drug therapy
  • Immunoglobulin G4-Related Disease / immunology*
  • Immunologic Factors / administration & dosage
  • Male
  • Middle Aged
  • Plasma Cells / immunology
  • Rituximab / administration & dosage

Substances

  • Biomarkers
  • Immunologic Factors
  • Rituximab

Supplementary concepts

  • Aortic Aneurysm, Familial Thoracic 1